论文信息 - Tyrosine kinase inhibitor CEP-701 blocks the NTRK1/NGF receptor and limits the invasive capability of prostate cancer cells in vitro. - 字舞流文

Tyrosine kinase inhibitor CEP-701 blocks the NTRK1/NGF receptor and limits the invasive capability of prostate cancer cells in vitro.

E. Ricevuto | C. Vicentini | M. Bologna | D. Millimaggi | V. Dolo | G. Gravina | C. Festuccia | P. Muzi | S. Speca